...
首页> 外文期刊>Oncology letters >A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma
【24h】

A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma

机译:GWAS鉴定的11q13.3染色体易感基因座及其推定的分子靶点,可预测人肾细胞癌的术后预后

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Genome-wide association studies have been used to identify single nucleotide polymorphisms (SNPs) associated with renal cell carcinoma (RCC) in European individuals. The current study aimed to evaluate the correlation between significant SNPs identified in European individuals and the occurrence and postoperative prognosis of RCC in Chinese individuals. A total of 400 cases and 806 controls were involved in the current study. rs4765623, rs7105934, rs7579899 and rs1867785 were genotyped using qPCR, and the expression of cyclin D1 in renal tissue and RCCs was determined via western blotting and immunohistochemistry. The correlation between the SNPs/cyclin D1 expression and overall survival was evaluated using multivariate Cox regression analyses. Of the four SNPs, only rs7105934 was found to significantly correlate with RCC risk in Chinese individuals. The rs7105934 GA + AA genotype was correlated with a reduced risk of RCC with an odds ratio of 0.64 (95% confidence interval [CI], 0.43-0.96), following adjustment for age. This genotype was found to independently predict an improved postoperative prognosis in the multivariate analysis, with a hazard ratio (HR) of 0.12 (95% CI, 0.02-0.93). Expression of cyclin D1, a putative regulated protein of rs7105934, did not vary in adjacent renal tissue and tumors when compared with that of various rs7105934 genotypes. However, cyclin D1 expression in RCCs inversely correlated with advanced tumor stage, and moderate to high expression of cyclin D1 in RCCs independently predicted improved postoperative prognosis, with an HR of 0.13 (95% CI, 0.02-0.96). Observations of the present study indicate that the rs7105934 A allele is associated with reduced risk and improved postoperative prognosis of RCC; however, this effect is unlikely to be caused by cyclin D1 expression.
机译:全基因组关联研究已用于鉴定与欧洲个体中与肾细胞癌(RCC)相关的单核苷酸多态性(SNP)。本研究旨在评估在欧洲个体中发现的重要SNP与中国个体RCC的发生和术后预后之间的相关性。本研究共涉及400例和806例对照。使用qPCR对rs4765623,rs7105934,rs7579899和rs1867785进行基因分型,并通过Western印迹和免疫组织化学检测肾组织和RCC中细胞周期蛋白D1的表达。使用多变量Cox回归分析评估SNP / cyclin D1表达与总生存率之间的相关性。在这四个SNP中,仅rs7105934被发现与中国人的RCC风险显着相关。调整年龄后,rs7105934 GA + AA基因型与RCC风险降低相关,比值比为0.64(95%置信区间[CI]为0.43-0.96)。在多变量分析中,发现该基因型可独立预测术后预后的改善,风险比(HR)为0.12(95%CI,0.02-0.93)。与各种rs7105934基因型相比,在邻近的肾组织和肿瘤中,cyclin D1(一种可能是rs7105934的调节蛋白)的表达没有变化。然而,RCCs中cyclin D1的表达与肿瘤的晚期呈负相关,而RCCs中或高表达的cyclin D1独立地预示了术后预后的改善,HR为0.13(95%CI,0.02-0.96)。本研究的观察结果表明,rs7105934 A等位基因与RCC的风险降低和术后预后改善相关。但是,这种作用不太可能由细胞周期蛋白D1的表达引起。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号